Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study. - Bromberg, Jacoline E C; Issa, Samar; Bakunina, Katerina; Minnema, Monique C; Seute, Tatjana; Durian, Marc; Cull, Gavin; Schouten, Harry C; Stevens, Wendy B C; Zijlstra, Josee M; Baars, Joke W; Nijland, Marcel; et al. (Lancet Oncology, 2019)